Effect of Intraoperative Infiltration With Bupivacain on the Development of Chronic Pain After Inguinal Hernia Repair
CompletedNot applicableNCT00484731
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The effect of intraoperative infiltration of the operation site with bupivacain on the development of chronic pain is the object of our trial. We hypothesize that the occurrence of chronic pain in the goup of patients receiving the infiltration will be 50% less than in the placebo group receiving normal saline. The study is a randomized controlled triple blinded trial with a sequential study design.
Study details
- Official title
- Investigating the Effect of Intra-operative Infiltration With Local Anaesthesia on the Development of Chronic Postoperative Pain After Inguinal Hernia Repair. A Randomized Placebo Controlled Triple Blinded and Group Sequential Study Design
- Conditions
- Interventions
- Procedure: Infiltration with Saline
- Procedure: Infiltration with Bupivacaine
- Sponsor
- Luzerner Kantonsspital
- Start date
- 2006-07
- Primary completion
- 2011-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Switzerland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult patients (≥ 18 years) with primary or recurrent single or double sided symptomatic but not incarcerated inguinal hernias with an elective hernia repair are included. * No other interventions (i.e. umbilical hernia) are allowed. * Written informed consent needs to be obtained. Exclusion Criteria: * Patients with legal incompetence, * Pregnant and nursing women, * Patients with presence or history of active malignancy or systemic diseases, * Under immunosuppressive treatment, * With systemic or severe local inflammation or infection, * With wound healing disorders and with physical or mental incapacity, which makes it impossible to obtain informed consent are excluded. * As pacemakers interfere with the electrical stimulation of the Pain Matcher® and vice versa patients with pacemakers or other implanted electrical devices were also excluded.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00484731